Topcon Healthcare Strengthens AI Platform for Ophthalmology: Strategic Acquisition and New Investments

Topcon Healthcare, a global leader in medical technology, has announced two strategic moves aimed at enhancing its artificial intelligence (AI) solutions. These include a deal to acquire Toku, Inc. and securing an investment from Sanro Health, Inc. These measures are aimed at revolutionizing predictive and preventive ophthalmology. A key event was the acquisition of Toku,…

Topcon Acquires IRIS to Expand AI-Powered Retinal Screening Capabilities

Topcon Healthcare has announced the acquisition of Intelligent Retinal Imaging Systems (IRIS), a company specializing in cloud-based retinal screening powered by artificial intelligence (AI). This acquisition will strengthen Topcon’s Healthcare from the Eye initiative and improve early diagnosis of diabetic retinopathy and other eye diseases. Enhancing Care Coordination Between Physicians The Healthcare from the Eye program aims to streamline…

EnVista Envy: A proven platform for complete freedom from glasses. Study data has been published

Bausch + Lomb announced the results of a large-scale clinical study of its newest intraocular lens (IOL), the enVista® Envy™. Data published in the authoritative American Journal of Ophthalmology confirms that this lens provides patients with continuous high-quality vision – from distance to near – with minimal visual disturbances after cataract surgery. Study Details: A Technology Comparison…